A nervous wait to Fuji’s decision. I can’t find a reason why they wouldn’t take up the option besides a tactical move to keep the share price down and launch a takeover bid, which would hopefully turn into a takeover war!
If they do take up the option this would be imo a company maker.
In addition, the license option agreement includes
a) an option to negotiate a licence for manufacturing CYP-001 product and
b) certain rights to Cynata’s proprietary Cymerus technology for the prevention and treatment of
other diseases.
Exercise of the rights to these additional components attracts further fees.
We could expect news to come in thick and fast and be on our way to building a multi billion dollar company!
Ann: Positive 28-day Clinical Trial Data in Cohort B, page-50
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 20.0¢ | $26.24K | 131.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 78722 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 15873 | 1 |
View Market Depth
| Last trade - 15.34pm 16/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |